More Than Half Of U.S. Has Taken COVID Vaccine

( The push to get as many Americans as possible vaccinated for COVID-19 is apparently working pretty well.

On Sunday, the White House announced that half of all adults in the United States have received at least one dose of a COVID-19 vaccine. This includes the one-shot does of Johnson & Johnson (which is currently paused) or at least one shot of the two-dose vaccines manufactured by Pfizer and Moderna.

Nearly 130 million Americans who are at least 18 years of age have received at least one dose of the vaccine. According to the Centers for Disease Control and Prevention, this represents 50.4% of the total adult population in the U.S.

Nearly 84 million adults are now fully vaccinated, which represents 32.5% of the total population. A person is considered fully vaccinated if they are at least one week removed from the second dose of the Pfizer vaccine, or at least two weeks removed from the second dose of Moderna or single dose of Johnson & Johnson.

The Johnson & Johnson vaccine was paused last week due to concerns about severe, but very rare, blood clots experienced by some who received it. This pause isn’t expected to last long, though.

When the vaccine does resume, it’s likely that it will come with some restrictions or even broader warnings about potential side effects.

Advisers to the CDC are set to meet Friday to discuss the Johnson & Johnson vaccine pause. Dr. Anthony Fauci said he expects them to make a decision during that meeting. As he said in some interviews recently:

“I would be very surprised if we don’t have a resumption in some form by Friday. I don’t really anticipate that they’re going to want to stretch it out a bit longer.”

Fauci, who serves as the chief medical adviser to President Joe Biden, said he believed regulators may allow the Johnson & Johnson vaccine again with potential restrictions on either gender or age. He also said there could be blanket warnings issued so the vaccine is administered “a little bit different than we were before the pause.”

The CDC as well as the Food and Drug Administration recently said they needed to gather additional evidence on whether the rare blood clots reported were linked to the Johnson & Johnson shot. If they were, the two groups needed to determine how big the risk was. That’s why they put the vaccine on pause until more information could be gathered.

The blood clots were reported in only six women out of more than 7 million people in the U.S. who have received the Johnson & Johnson vaccine. All women were between 18 and 48 years old. One of those women died as a result.

Fauci said he doesn’t believe the pause would turn into a permanent ban on Johnson & Johnson’s vaccine. He said:

“I don’t think that’s going to happen. The pause was to take a look, make sure we know all the information we can have within that timeframe, and also warn some of the physicians out there who might see people, particularly women, who have this particular adverse event, that they treat them properly.

“I think it’ll likely say, ‘Okay, we’re going to use it. But be careful under these certain circumstances.'”